Autism and measles-mumps-rubella (MMR) vaccination: a challenge for pharmacoepidemiology.

Abstract

Pharmacotherapy: The Journal of Human Pharmacology and Drug TherapyVolume 23, Issue 12 p. 1521-1523 Free Access Autism and Measles-Mumps-Rubella (MMR) Vaccination: A Challenge for Pharmacoepidemiology David C. G. Skegg M.B., D.Phil., Corresponding Author David C. G. Skegg M.B., D.Phil. Professor Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.Department of Preventive and Social Medicine, University of Otago, P.O. Box 913, Dunedin, New Zealand; e-mail: [email protected].Search for more papers by this author David C. G. Skegg M.B., D.Phil., Corresponding Author David C. G. Skegg M.B., D.Phil. Professor Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.Department of Preventive and Social Medicine, University of Otago, P.O. Box 913, Dunedin, New Zealand; e-mail: [email protected].Search for more papers by this author First published: 16 January 2012 https://doi.org/10.1592/phco.23.15.1521.31956Citations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Kanner L. Autistic disturbances of affective contact. Nervous Child 1943; 2: 217– 50. 2 World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992: 252– 9. 3 American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994: 66– 78. 4 Wing L. The autistic spectrum. Lancet 1997; 350: 1761– 6. 5 Medical Research Council. MRC review of autism research—epidemiology and causes. December 2001. Available from www.mrc.ac.ukpdf-autism-report.pdf. Accessed September 2003. 6 Bailey A., Le Couteur A., Gottesman I., et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995; 25: 63– 77. 7 Fombonne E. The epidemiology of autism: a review. Psychol Med 1999; 29: 769– 86. 8 Yeargin-Allsopp M., Rice C., Karapurkar T., Doernberg N., Boyle C., Murphy C. Prevalence of autism in a US metropolitan area. JAMA 2003; 289: 49– 55. 9 Wakefield AJ, Murch SH, Anthony A., et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637– 41. 10 Furlano RI, Anthony A., Day R., et al. Colonic CD8 and γδ T-cell infiltration with epithelial damage in children with autism. J Pediatr 2001; 138: 366– 72. 11 Chen RT, DeStefano F. Vaccine adverse events: causal or coincidental? Lancet 1998; 351: 611– 12. 12 Anonymous.. Measles, MMR, and autism: the confusion continues [editorial]. Lancet 2000; 355: 1379. 13 Bignall J. UK experts convinced on safety of MMR. Lancet 1998; 351: 966. 14 Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 1998; 351: 356– 61. 15 Lee JW, Melgaard B., Clements CJ, Kane M., Mulholland EK, Olive J-M. Autism, inflammatory bowel disease, and MMR vaccine [letter]. Lancet 1998; 351: 905. 16 Wakefield AJ MMR vaccination and autism [letter]. Lancet 1999; 354: 949– 50. 17 Taylor B., Miller E., Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999; 353: 2026– 9. 18 Kaye JA, Melero-Montes MM, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001; 322: 460– 3. 19 Dales L., Hammer SJ, Smith NJ Time trends in autism and in MMR immunization coverage in California. JAMA 2001; 285: 1183– 5. 20 Madsen KM, Hviid A., Vestergaard M., et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002; 347: 1477– 82. 21 Wilson K., Mills E., Ross C., McGowan J., Jadad A. Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine. Arch Pediatr Adolesc Med 2003; 157: 628– 34. 22 Skegg DCG. Medical record linkage. In: WHW Inman, ed. Monitoring for drug safety. 2nd ed. Boston: MTP Press, 1986: 291– 303. 23 Rodriguez Garcia LA, Gutthann Perez S Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998; 45: 419– 25. 24 Black C., Kaye JA, Jick H. Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. BMJ 2002; 325: 419– 21. 25 Jick H., Kaye JA Epidemiology and possible causes of autism. Pharmacotherapy 2003; 23: 1524– 30. 26 Croen LA, Grether JK, Hoogstrate J., Selvin S. The changing prevalence of autism in California. J Autism Dev Disord 2002; 32: 207– 15. 27 Venning GR. Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems. BMJ 1983; 286: 458– 60. 28 Baum C., Kweder SL, Anello C.. The spontaneous reporting system in the United States. In: BL Strom, ed. Pharmaco-epidemiology. 2nd ed. New York: John Wiley, 1994: 125– 37. 29 Wiholm B-E, Olsson S., Moore N., Wood S.. Spontaneous reporting systems outside the United States. In: BL Strom, ed. Pharmacoepidemiology. 2nd ed. New York: John Wiley, 1994: 139– 55. Citing Literature Volume23, Issue12December 2003Pages 1521-1523 ReferencesRelatedInformation